Daily Stock List
Kenergy Scientific, Inc. (KNSC)
Real Pennies reported recently on Kenergy Scientific, Inc. (KNSC), Wallstreetlivechat, SuperNova Elite did earlier, and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Kenergy Scientific, Inc. is a media marketing services company that lists on the OTC Markets’ OTCQB. It operates a business media company - SparX Business Media. SparX helps companies' marketing and advertising budgets yield the highest Return on Investment (ROI). SparX began as a start-up company in 2013. It has since attracted lucrative contracts and customers in the energy, beverage and agro industry arena. In addition, Kenergy Scientific is launching its marijuana website. The Company previously went by the name SpeechSwitch, Inc. It changed its name to Kenergy Scientific, Inc. in February of 2011.
The Company’s SparX Business Media delivers functional communications for any business. SparX offers and customizes a series of high-impact marketing efforts, which communicate a clear, relevant message to a company’s target audience, builds revenue and solidifies customer loyalty. It offers a multifaceted approach to marketing, combining cyber-age marketing methods with traditional print media and direct marketing methods. SparX offers radio, TV, print, outdoor, online, mobile, social media and advertising solutions.
Regarding its marijuana initiative, Kenergy Scientific focuses on updating the general public on the latest breaking news on marijuana, legalization updates, and latest cannabis products, history of cannabis, newsletters subscription, and latest videos on the topic, blogs, and insightful community conversations concerning marijuana. The Company will release articles on Marijuana products, its safe usage, as well as its legal obligations.
Today, Kenergy Scientific announced the preview launch of its marijuana portal Stoned Pilots.Com. Stoned Pilots is being built as a site for the marijuana industry. It will offer vertical growth and chain management supply methodology through technology chiefly by way of smart phone, tablets and other mobile devices (SMT). The Stoned Pilots V1 site will launch soon. Stoned Pilots V2 development is presently well under way, and expected soon. The V2 version will offer the full complement of SMT features and functionality.
Kenergy Scientific, Inc. (KNSC), closed Monday's trading session at $0.001, down 9.09%, on 63,889,520 volume with 111 trades. The average volume for the last 60 days is 101,824,965 and the stock's 52-week low/high is $0.0001/$0.0019.
Catasys, Inc. (CATS)
RedChip reported earlier on Catasys, Inc. (CATS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Catasys, Inc. is a provider of proprietary health management services to health insurers and employers. It provides specialized health management services through a network of licensed and company managed health care providers. Catasys established to serve health care payors, and provides innovative and integrated substance dependence treatment solutions for its members. The Company’s senior management team has 50-plus years of substance dependence experience and 100-plus years of health care experience. OTC Bulletin Board listed Catasys is based in Los Angeles, California.
The Catasys substance dependence program improves member health, consequently lowering overall costs. The proprietary program addresses substance dependence as a chronic disease. The program focuses on the whole health of the member. The program delivers integrated medical and psychosocial interventions in combination with long-term care coaching.
The design of the Company’s OnTrak program is to improve member health and simultaneously lower costs to the insurer through utilizing patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. Currently, Catasys provides its proprietary OnTrak integrated substance dependence solutions for third-party payors in Kansas, Kentucky, Louisiana, Massachusetts, Oklahoma, West Virginia and Wisconsin. As of the end of 2013, Catasys had a sales pipeline of 13 million covered lives with 3 million in advanced stages of discussion.
At the beginning of April, Catasys announced financial results for the fourth quarter ended December 31, 2013. Total revenues increased 161 percent to $468,000 versus $179,000 for the same period the year prior. Increased total revenues were mainly a result of an increase in healthcare services revenue.
Catasys reported a loss from operations before taxes of $1,494,000, or $(0.08) per basic and diluted share, for the fourth quarter of 2013, versus a loss of $5,777,000, or $(0.66) per basic and diluted share, in the fourth quarter of the year prior. The financial statements have been retroactively restated to reflect the 10-for-1 reverse stock split that took place on May 6, 2013. Total operating expenses for the fourth quarter of 2013 were $2,555,000, down 5 percent, or $116,000 in comparison to the fourth quarter in 2012.
Catasys, Inc. (CATS), closed Monday's trading session at $1.31, up 4.80%, on 101 volume with 2 trades. The average volume for the last 60 days is 12,876 and the stock's 52-week low/high is $0.75/$1.60.
Millennium HealthCare, Inc. (MHCC)
We are reporting on Millennium HealthCare, Inc. (MHCC) today, here at the QualityStocks Daily Newsletter.
Millennium HealthCare, Inc., via its wholly owned operating subsidiaries, provides primary care physician practices, physician groups, and healthcare facilities of all sizes with leading-edge medical devices focused primarily on preventive care through early detection. The Company previously went by the name Zen Holdings Corp. It changed its name to Millennium Healthcare, Inc. in July 2011. The Company operates in three segments: Coding, Device, and Vascular. Millennium HealthCare has its corporate office in Garden City, New York.
Millennium purchases, supplies, and distributes innovative medical devices and equipment with a focus on prevention and early detection. In addition, it provides physician practice development, support, and administration services for physician facilities and practices principally for vascular disorders, including peripheral arterial disease of the lower extremities. Moreover, the Company offers support and services specializing in medical procedure billing and collections, medical procedure coding, call and message management, as well as emergency dispatch.
In early December 2013, Millennium HealthCare, through its wholly owned subsidiary Millennium ProComm Solutions, Inc. (ProComm), announced the acquisition of certain assets of Bellringer Communications, Inc. Bellringer is a well-established, privately held, telephone answering service owned by a security company specializing in monitoring and central service, serving Long Island and the five boroughs of New York, New York.
Millennium HealthCare’s ProComm subsidiary provides a wide array of services to physicians, hospitals, home care agencies, hospices, clinics, nursing homes and other service professionals in New York State and on a nationwide basis. This includes 24-hour phone answering and inbound message taking services.
Recently, Millennium HealthCare announced that its subsidiary, Millennium Medical Devices, signed an exclusive agreement with CDx Diagnostics for distribution of DermCDx™, a brush biopsy test kit used to confirm suspected basal cell carcinoma (BCC). DermCDx is a minimally invasive test. It combines a patented brush biopsy sampling instrument with computer-assisted three dimensional laboratory analysis.
Last week, Millennium HealthCare announced that Millennium Medical Devices signed another network selling agreement. This agreement was signed with a U.S. based healthcare organization for the use of Millennium's medical devices in 400 of the organization's locations. This agreement includes an average monthly minimum use of 350 units per device, per location. The network selling agreement includes the use of the VasoScan cardiovascular assessment test. The Company has exclusive distribution rights for the VasoScan device.
Millennium HealthCare, Inc. (MHCC), closed Monday's trading session at $0.96, down 3.03%, on 91,637 volume with 55 trades. The average volume for the last 60 days is 84,089 and the stock's 52-week low/high is $0.2001/$1.50.
Bluesphere Corp. (BLSP)
Penny Stock Explosion, Liquid Tycoon, Penny Stock Pick Alert, Super Nova Stock Picks, Super Hot Penny Stocks, Penny Stock Money Train, and Penny Stock Pick Report reported previously on Bluesphere Corp. (BLSP), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
Bluesphere Corp. is working to become a key player in the global waste-to-energy and renewable energy markets. In essence, the Company is a waste-to-energy project integrator. It has a business plan that fits the changing regulatory standards for waste and energy. Bluesphere is an international enterprise that develops, manages, and owns waste-to-energy projects. Its main business model is BOO (Build-Own-Operate): long-term energy agreements are executed with electric companies in advance of projects. Bluesphere has projects in North Carolina, Rhode Island, and Ghana.
At present, the Company is concentrating on four projects for which it has signed agreements, term sheets or memoranda to own and implement such projects and which are in diverse stages of development. In the United States it has its Charlotte, North Carolina Waste to Energy Anaerobic Digester 5.2 MW Plant. In Johnston, Rhode Island it has its Waste to Energy Anaerobic Digester 3.2 MW Plant. In Ghana it has its Oti Sanitary Landfill Waste to Energy 1 MW Plant and Accra Transfer Station Waste to Energy Anaerobic Digester 10MW Plant.
In March, Bluesphere announced that its wholly-owned subsidiary signed a Joint Venture Agreement with Alfa Eco Corp. Alfa Eco is a leading private business group, which consists of direct investment funds owning and managing assets in a range of industries. This includes energy in the U.S. and internationally. Alfa Eco has strategic partnerships in Bulgaria, Brazil, China, Kazakhstan, Mongolia, Russia, Sierra Leone, Switzerland, Ukraine and other countries. Bluesphere and Alfa Eco will form a joint venture corporation jointly owned by the companies on a 50/50 basis. With this joint venture, the companies will develop turn-key and build-own-operate (BOO) waste-to-energy projects.
In addition, last month, Bluesphere announced that it signed a Letter of Intent (LOI) with Organic Waste Management, LLC, a company with more than 35 years in the recycling and waste industries. Organic Waste Management will supply between 100-200 tons of organic waste daily to Bluesphere's 3.2 MW biogas plant to be constructed later this year in Johnston, Rhode Island.
Bluesphere Corp. (BLSP), closed Monday's trading session at $0.1301, down 12.09%, on 27,765 volume with 10 trades. The average volume for the last 60 days is 87,119 and the stock's 52-week low/high is $0.05/$0.625.
JBI, Inc. (JBII)
AllPennyStocks, Stock Analyzer, PennyStockLive, Stock Traders Chat, Penny Stock Finder, Beacon Equity Research, and Stock Preacher reported previously on JBI, Inc. (JBII), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
JBI, Inc. is a clean energy company that lists on the OTC Markets’ OTCQB. The Company recycles waste plastic into liquid fuels. Its proprietary Plastic2Oil® technology (P20) can deliver economic and environmental benefits through replacing refined fuels and diverting waste plastic from landfills. JBI’s patent pending Plastic2Oil® process transforms unsorted, unwashed waste plastic into ultra-clean, ultra-low sulphur fuel without the need for refinement. JBI has determined that joint ventures and P2O Processor sales will be the principal focus of its business plan moving forward. JBI is headquartered in Niagara Falls, New York.
The No. 6 Fuel produced by JBI by the P2O process is much cleaner than the existing industry standard. It contains less than 16 ppm of sulphur in comparison to the maximum of 30,000 ppm allowable in mainstream No. 6 Fuels. No. 6 Fuel is heavy fuel typically used in industrial boilers and ships. In addition, JBI can produce Fuel No.2 (Diesel, Petroleum Distillate), Naphtha, as well as Petcoke (Carbon Black).
JBI sells its fuel products through three channels. These are fuel brokers, fuel retailers, and direct to end users. Presently, JBI has four primary agreements in place for the sale of its fuels. Currently, JBI is permitted to operate at a rate of 4,000 lbs. of plastic feedstock per hour per machine at its Niagara Falls facility.
The Company has a referral and revenue sharing agreement with Rock-Tenn Company to convert mill by-product waste into fuel using the Plastic2Oil® technology. With this agreement, JBI has a 10-year license, with a renewal option, to build and operate P2O processors at RockTenn facilities, to process RockTenn's waste plastic at paper mills and Material Recovery Facilities, and to mine and process plastic from RockTenn's plastic-filled mono-fill sites. JBI’s near-term growth plans include continued build-out of the Niagara Falls facility and the first RockTenn site.
Recently, JBI announced that it hired Mr. Rahoul S. Banerjea, CPA as its Chief Financial Officer (CFO).
Mr. Banerjea, CPA, has broad expertise working with publicly traded, international high technology and manufacturing companies. He has served in financial leadership roles at several public and private companies since 1972. This includes Compaq/Digital Equipment Corp., which is now part of Hewlett-Packard Co.
JBI, Inc. (JBII), closed Monday's trading session at $0.18, up 9.09%, on 97,880 volume with 32 trades. The average volume for the last 60 days is 183,445 and the stock's 52-week low/high is $0.06/$0.68.
Speedemissions, Inc. (SPMI)
The QualityStocks Daily Newsletter would like to spotlight Speedemissions, Inc. (SPMI). Today, Speedemissions, Inc. closed trading at $0.007, up 34.62%, on 411,653 volume with 13 trades. The stock’s average daily volume over the past 60 days is 734,958, and its 52-week low/high is $0.0006/$0.09.
Speedemissions, Inc. (SPMI) operates 43 vehicle emissions testing and safety inspection stations under the trade names of Speedemissions and Auto Emissions Express; Mr. Sticker; and Just Emissions. As one of the largest test-only emissions testing and safety inspection companies in the United States, Speedemissions is well positioned in a $2.5 billion market where 87 million vehicles tested annually on emissions quality.
In 2001, the company was founded for the sole purpose of developing its own vehicle emission testing stations and to make strategic acquisitions of competitors in markets poised for growth. Today, in addition to opening new stores and acquiring other retail operations, Speedemissions is accelerating its business and margin growth by adding automotive repair and maintenance services to existing locations.
In June 2010, the Company announced the launch of its first proprietary technology application called “CARbonga” that diagnoses an automobile’s computer system using the on-board diagnostic port on vehicles that were produced since 1996. CARbonga is the world’s first app initially for the iPhone®, iPad® and iPod touch®, designed to provide motorist with easy access to the same technology for their vehicles Safety Systems and On-Board-Diagnostic Systems (OBD) codes, previously available only to car repair mechanics & dealerships. The real-time diagnostic information obtainable addresses key safety systems as anti-lock brakes, air-bags, tire pressure monitor, vehicle emissions, among others, and can check over 2,000 vehicle fault codes. The “CARbonga-SRI” app gives car owners easy access to any vehicle’s history when it comes to Safety Recall Notices and TSB’s (Technical Service Bulletins) issued by the automobile manufacturer.
The company’s main strategies for expansion will be to continue to follow its core growth blueprint of opening new stores and acquiring existing retail operations, while converting a database of over 300,000 customers into long-term brand-loyal advocates and full-service automotive customers. With a fast-growth business model and large footprint already in place, Speedemissions is poised to achieve tremendous success. Disclaimer
Speedemissions, Inc. Company Blog
Speedemissions, Inc. News:
Speedemissions, Inc. Reports Year End 2013 Results
Speedemission Inc. Rebrands Itself While Offering New In-Store Vehicle Registration
Speedemissions, Inc. CEO Discusses Significance of CARbonga, Its Auto Safety & Recall App on Business Radio's "Silver Lining in the Cloud"
NutraNomics, Inc. (NNRX)
The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.139, up 19.83%, on 379,525 volume with 51 trades. The stock’s average daily volume over the past 60 days is 356,278, and its 52-week low/high is $0.0605/$1.48.
NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.
Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.
Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.
NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer
NutraNomics, Inc. Company Blog
NutraNomics, Inc. News:
Nutranomics Discusses Long-Term Global Expansion Strategy with UNO International Corp.
Nutranomics Receives Initial Purchase Order from Leading Health Products Distributor in the Philippines
Nutranomics Announces Exclusive Shareholder Product Promotion
P2 Solar, Inc. (PTOS)
The QualityStocks Daily Newsletter would like to spotlight P2 Solar, Inc. (PTOS). Today, P2 Solar, Inc. closed trading at $0.035, up 16.28%, on 35,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 50,485, and its 52-week low/high is $0.0122/$0.08.
P2 Solar, Inc. (PTOS) participates in the lucrative renewable energy market as a developer of solar photovoltaic (PV) power projects, focusing its initiatives on “sunbelt” areas where sunlight exposure is abundant; renewable energy policies are favorable; public and private sectors are actively seeking to incorporate solar PV into their electricity consumption profiles; and where governments offer attractive subsidies to motivate development.
Acknowledging rising demand for clean energy worldwide, solar PV power’s increasingly competitive edge over grid electricity, and commercial efforts to reduce reliance on greenhouse gas emitting fossil fuels, P2 Solar invests and channels its resources to benefit from these global trends.
The company’s growth strategy centers on management’s aggressive mandate to develop 150 MWp of electricity generating capacity in several phases over the next few years. To this accord, the company is focused on further development of its project portfolio, which currently consists of the Langley Rooftop Project in British Columbia; the Rajgarh Mini-hydro Project in Punjab, India; and the Tibba Mini-hydro Project, also located in Punjab India.
Backed by executive leadership with more than 60 years of combined experience, P2 Solar continues to develop and expand its current projects while opportunistically pursuing development opportunities in other regions with favorable solar energy regimes, including Eastern Europe and Canada. Disclaimer
P2 Solar, Inc. Company Blog
P2 Solar, Inc. News:
P2 Solar Update on Langley Rooftop Project
P2 Solar Acquires Its Second Renewable Energy Project in India
P2 Solar Langley Rooftop Project Status Update
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.1695, up 5.28%, on 407,033 volume with 78 trades. The stock’s average daily volume over the past 60 days is 652,649, and its 52-week low/high is $0.13/$0.34.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
Lifeline Skin Care Expands Into Latin America's Second Largest Market
International Stem Cell Corporation Announces 2013 Fourth Quarter and Year-End Results
International Stem Cell Corporation to Host Full-Year 2013 Business Update and Financial Results Conference Call Wednesday, March 19, 2014
Innocent, Inc. (INCT)
The QualityStocks Daily Newsletter would like to spotlight Innocent, Inc. (INCT). Today, Innocent, Inc. closed trading at $0.0131, even for the day, on 3,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,620, and its 52-week low/high is $0.0005/$0.092.
Innocent, Inc. (INCT) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.
The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Innocent aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.
Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Innocent has strategically added extensive technical guidance and field management experience.
Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Innocent is well positioned to generate substantial revenues in the short and long term future. Disclaimer
Innocent, Inc. Company Blog
Innocent, Inc. News:
Innocent Inc. Announces Letter to Shareholders
Innocent Inc. Announces New Joint Venture to Explore for Oil and Gas
Innocent, Inc. (INCT) is "One to Watch"
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Armco Metals Holdings, Inc. (AMCO) and Midland Resources Enter Into Steel Scrap Supply Agreement
- China Logistics Group, Inc. (CHLO) Pursues Strategic Acquisition Candidates
- Colt Resources Inc. (COLTF) provides Operational Update on Portuguese projects
- Consorteum Holdings, Inc. (CSRH) and The Alternative Initiate New Brand Development Project
- eCrypt Technologies, Inc. (ECRY) Appoints Former Microsoft Engineer to Advisory Board
- Global Payout, Inc. (GOHE) & New Payment Solutions Unveil Innovative New Tax Refund Payment Platform Creating Another New Market Niche
- GlobalWise Investments, Inc. (GWIV) Investments Announces Results for Fiscal Year 2013
- Great Plains Holdings, Inc. (GTPH) President to Exhibit and Present at the Las Vegas MoneyShow
- Infinite Group, Inc. (IMCI) Cybersecurity In Focus At IMCI With New Hire
- Innocent, Inc. (INCT) Announces Letter to Shareholders
- International Stem Cell Corp. (ISCO) Lifeline Skin Care Expands Into Latin America's Second Largest Market
- Kallo, Inc. (KALO) Announces Appointment of Two Senior Managers
- Mabwe Minerals Inc. (MBMI) Raptor Resources Holdings Completes Expansion of the Dodge Mine Mountain Range
- NeuroMama, Ltd. (NERO) CES Event Showcasing Intelligent Search Engine, Online Retail Platform and Advertising Opportunities, Reception Act Performer Fall and Serious Injuries Documented
- NutraNomics, Inc. (NNRX) Discusses Long-Term Global Expansion Strategy with UNO International Corp.
- P2 Solar, Inc. (PTOS) Update on Langley Rooftop Project
- Pan Global Corp. (PGLO) Increases Equity Stake in Small-Hydro Plant in Northern India
- Raptor Resources Holdings Inc. (RRHI) Acquires the Derbyshire Stone Quarry
- Speedemissions, Inc. (SPMI) Reports Year End 2013 Results
- Start Scientific, Inc. (STSC) is “One to Watch”
- Victory Energy Corp. (VYEY) Engages Euro Pacific Capital
- VistaGen Therapeutics, Inc. (VSTA) Joins the Cardiac Safety Research Consortium
- Well Power Inc. (WPWR) Closes First Round Of Funding
- Zenosense, Inc. (ZENO) Enters Into $475,000 Securities Purchase Agreement